General Prognostics Inc.

50 Milk Street
16th Floor
Boston,  MA  02109

United States
  • Booth: FH18

GPx is pioneering Bloodless Blood Tests by leveraging AI to calibrate digital biomarkers collected from wearables with vital blood biomarkers and delivering clinically actionable information about Heart Failure blood biomarker changes on a timely and cost-effective basis. Unlike all other HF remote monitoring platforms, we pair the simplicity and cost effectiveness of digital biomarkers with the high-accuracy and insight supplied by blood biomarkers. This unique staging of digital/blood biomarkers provides clinicians with insight into patients’ status in their day-to-day language, Class I guideline-recommended blood biomarkers like NT-proBNP and creatinine, ensuring that our signals are trustworthy and fit into current clinical workflows.

 Additional Info

We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
ACC.23 Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies
First time Exhibitor?